-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-241-bmi-communication-full-report.pdf
February 01, 2020 - Measure Categories
CHIPRA legislation requires that measures in the initial and improved core set, taken … for the focus of the measures will be made explicit and transparent as
part of the public release of CHIPRA … Identification of Disparities
CHIPRA requires that quality measures be able to identify disparities … Levels of Aggregation
CHIPRA states that data used in quality measures must be collected and reported … Understandability
CHIPRA states that the core set should allow purchasers, families, and health care
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0192-table11-figures1-2.pdf
May 15, 2015 - Overuse of Imaging for the Evaluation of Children with Simple Febrile Seizure: Table 11 and Figures 1 & 2
Table 11: Evidence Regarding Overuse of Imaging for the Evaluation of Children with Simple Febrile Seizure
Type of
Evidence
Key Findings
Level of
Evidence
(USPSTF
Ranking*)
Citations
Clinica…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0198-table10-figures1-2.pdf
July 16, 2015 - Overuse of Computed Tomography Scans for the Evaluation of Children with a First Generalized Afebrile, Atraumatic Seizure: Table 10 and Figures 1 & 2
Table 10: Evidence Regarding Overuse of Imaging for the Evaluation of Children with Afebrile, Atraumatic
Seizures
Type of
Evidence
Key Findings
Level of
Ev…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0197-table6-figs1-2.pdf
July 16, 2015 - Ratio of Magnetic Resonance Imaging Scans to Computed Tomography Scans for the Evaluation of Children with Atraumatic Seizure: Table 6 and Figures 1 & 2
Table 6: Evidence Regarding Overuse of Imaging for Atraumatic Seizures in Children
Type of
Evidence
Key Findings
Level of
Evidence
(USPSTF
Ranking*) …
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-113-section-2-tech-specs.pdf
December 01, 2011 - Section 2, Technical Specifications
Technical Specifications: Rate of ED Visit Use for Children Managed for
Identifiable Asthma
Calculation
a. Step 1: Measure person-time eligible for each patient and record by month.
i. a. For each month in the reporting year, identify all children ages 2 – 21 years
wh…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-150-section-2-tech-specs.pdf
November 01, 2014 - National Collaborative for Innovation in Quality Measurement--Metabolic Monitoring for Children and Adolescents on Antipsychotics
1
National Collaborative for Innovation in Quality Measurement
Metabolic Monitoring for Children and Adolescents on Antipsychotics
Administrative Specification for Sta…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-126-section-2-technical-specs.pdf
June 02, 2025 - Use of Multiple Concurrent Antipsychotics in Children Section 2, Technical Specifications
National Collaborative for Innovation in Quality Measurement
Use of Multiple Concurrent Antipsychotics in Children
Administrative Specification
Measure Description
The percentage of children 0 to 20 years of a…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-216-section-2-tech-specs.pdf
June 02, 2025 - Sickle Cell Disease Technical Specifications
Sickle Cell Disease
Measure 15: Appropriate Emergency Department Fever Management
for Children with Sickle Cell Disease
Description
The percentage of children identified as having Sickle Cell Disease presenting to an emergency
department with fever during the me…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-177-section-2-technical-specs.pdf
May 23, 2014 - National Collaborative for Innovation in Quality Measurement
National Collaborative for Innovation in Quality Measurement
Administrative Sp…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-215-scd-ed-tech-specs.pdf
June 02, 2025 - Appropriate Emergency Department Blood Testing for Children with Sickle Cell Disease
Sickle Cell Disease
Measure 14: Appropriate Emergency Department Blood Testing for
Children with Sickle Cell Disease
Description
The percentage of children identified as having Sickle Cell Disease presenting to an eme…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-148-section-2-tech-specs.pdf
June 02, 2025 - with financial support from the Agency for Healthcare Research and Quality (AHRQ) and
CMS under the CHIPRA
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-166-fecc-table-6.pdf
June 02, 2025 - Section 6, Table 6 Construct Measurement Reliability Testing
Table 6: Construct measurement reliability testing for multi-part indicators
Number
of items
Average
inter-item
polychoric
correlation
Polychoric
Ordinal
Alp…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/outcomes/chipra-146-section-6-tables-1a.pdf
June 02, 2025 - Table 1a. ADAPT Survey Respondent Characteristics
…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-0121-tables-7-10.pdf
June 02, 2025 - Tables 7-10
TABLE 7
Quantile
Percent in Poverty
Maximum 49.9%
99 37.5%
95 28.9%
90 25.7%
75 20.7%
50 16.5%
25 12.5%
10 10.0%
5 8.6%
1 6.1%
Minimum 2.9%
TABLE 8
HROB Summary (Combined Unduplicated)
New York State Medicaid, 2010
Poverty
Level
N OB
Proxy1
Transfusion
…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-143-section-5a-evidence-table.pdf
January 01, 2014 - Table 5.A.1. Evidence Table
…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-143-section-6a-flow-chart.pdf
June 02, 2025 - Section 6.A Flow Chart
Figure VI.A.1 – Flowchart of the medical record review process in the GAPPS study
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-0121-tables-2-5.pdf
June 02, 2025 - Tables 2-5
TABLE 2
High-risk referral center Not a high-risk referral
center
P-value
Facility Type
Community hospital 61 (58.7%) 207 …
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-228-tables-1-2.pdf
June 02, 2025 - Section 1, Tables 1 and 2
Table 1: Definition of Sepsis Syndrome
Term Definition
Sepsis syndrome Sepsis, severe sepsis or septic shock
Sepsis Systemic Inflammatory Response Syndrome (SIRS) in the presence of, or as a result
of, suspected or proven infection
SIRS The presence of at least two of the following f…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0230-sepsis-antibiotics-technical-specs.pdf
August 01, 2014 - Timely Antiobiotics for Children With Severe Sepesis or Septic Shock Technical Specifications
Q-METRIC Sepsis Measure 4, Timely Administration of Antibiotics for Severe Sepsis and Septic Shock
U18HS020516 Page 50
Submitted August 2014
Sepsis
Measure 4: Timely Antibiotics for Children with Severe Sepsis or …
-
www.ahrq.gov/policymakers/chipra/overview/background/appendix-a6.html
December 01, 2009 - Background Report for the Request for Public Comment on Initial, Recommended Core Set of Children's Healthcare Quality Measures for Voluntary Use by Medicaid and CHIP Programs
Background Report on request for public comment on initial, recommended core set of Children's Healthcare Quality Measures for voluntary…